Herpes simplex virus-2-associated esophagitis in immunocompetent host

Haider A. Naqvi; Sumanthkumar Bandaru; Adrien L. Janvier; Muhammad Nadeem Yousaf

doi:10.5114/pg.2020.100757

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2021
vol. 16

Send email

Copy url:

abstract:

Letter to the Editor

Herpes simplex virus-2-associated esophagitis in immunocompetent host

Haider A. Naqvi

^{1, 2, 3, 4}

,

Sumanthkumar Bandaru

^{1, 2, 3, 4}

,

Adrien L. Janvier

^{3, 5}

,

Muhammad Nadeem Yousaf

^{1, 2, 3, 4}

Department of Medicine, Medstar Union Memorial Hospital, Baltimore, USA
Department of Medicine, MedStar Good Samaritan Hospital, Baltimore, USA
Department of Medicine, Medstar Franklin Square Medical Center, Baltimore, USA
Department of Medicine, MedStar Harbor Hospital, Baltimore, USA
Department of Medicine, MedStar Georgetown University Hospital, Washington, USA

Gastroenterology Rev 2021; 16 (3): 248–251

DOI: https://doi.org/10.5114/pg.2020.100757

Online publish date: 2021/01/07

View full text Get citation

PlumX metrics:

Herpes esophagitis (HE) is typically caused by herpes simplex virus type 1 (HSV-1), although less frequently, it is caused by HSV type 2 (HSV-2). Most cases of HE occur in immunocompromised hosts, but occasionally immunocompetent patients develop this condition. Thus, HSV-2 esophageal infection in immunocompetent individuals is comparatively rare [1]. Canalejo Castrillero et al. performed a review of published HE cases (English and Spanish language) in immunocompetent patients from 1950 to 2009. The HSV type was identified in only 27 out 56 cases. However, among the identified cases, 96% (26) were due to HSV-1 and only 4% (1) was due to HSV-2 [1]. The overall reported incidence of HE is 1.8% [2]. Common risk factors for HE include a history of HIV, AIDS, malignancy, solid organs transplant, use of steroids, immunosuppressant medications, chemotherapy, and radiation therapy [1, 3–7]. An estimated 10–15% of bone marrow transplant patients and up to 20% of AIDS patients may develop HE [8]. The mode of esophageal infection in immunocompromised individuals is either viral reactivation or new infection, whereas in immunocompetent individuals, new infection is the primary mode [1].

Herpes simplex virus-2-associated esophagitis in immunocompetent host

Haider A. Naqvi 1, 2, 3, 4 , Sumanthkumar Bandaru 1, 2, 3, 4 , Adrien L. Janvier 3, 5 , Muhammad Nadeem Yousaf 1, 2, 3, 4

Haider A. Naqvi

^{1, 2, 3, 4}

,

Sumanthkumar Bandaru

^{1, 2, 3, 4}

,

Adrien L. Janvier

^{3, 5}

,

Muhammad Nadeem Yousaf

^{1, 2, 3, 4}